Past Hsp90 webinars (2024)
January 29, 2024
Bruce M. Spiegelman (Dana-Farber Cancer Institute and Harvard Medical School, Boston, USA)
Irisin controls cognition and neurodegeneration through an αV/β5/HSP90α pathway
February 19, 2024
John D. Catravas (Frank Reidy Research Center for Bioelectrics, College of Health Sciences, Old Dominion University, Norfolk, VA)
HSP90 inhibitors in pre-clinical models of acute and chronic pulmonary pathologies
March 18, 2024
Daniella Goldfarb (Department of Chemical and Biological Physics, Weizmann Institute, Rehovot, Israel)
Hsp90 structural dynamics through the lenses of electron paramagnetic resonance
April 11, 2024
Marc B. Cox (Border Biomedical Research Center, The University of Texas at El Paso, El Paso, TX, USA)
Androgen receptor-associated FKBP cochaperones as novel targets for the treatment of prostate cancer
May 13, 2024
Ahmed Chadli (Augusta University, Augusta, Georgia, USA)
Unleashing the immune system against triple-negative breast cancer through inactivating the Hsp90 chaperoning machine